Alicaic v. Commissioner of Social Security

District Court, N.D. Iowa·Decided September 21, 2022·No. 6:21-cv-02035·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF IOWA EASTERN DIVISION

ELVIS ALICAIC,

Plaintiff, Case No. 21-CV-2035-KEM

vs. MEMORANDUM OPINION KILOLO KIJAKAZI, AND ORDER Acting Commissioner of Social Security,

Defendant. ____________________ Plaintiff Elvis Alicaic seeks judicial review of a final decision of the Commissioner of Social Security denying his application for disability insurance (DI) benefits under Title II of the Social Security Act, 42 U.S.C. §§ 401-434. Alicaic argues that the administrative law judge (ALJ) erred in determining his residual functional capacity (RFC). I find that substantial evidence does not support the ALJ’s finding that Alicaic could frequently handle and finger, and I reverse the Commissioner’s decision and remand for an award of benefits.

I. BACKGROUND1 Alicaic, born in 1981, worked full-time for years as a quality control inspector at a meatpacking plant; prior to that, he had worked full-time on the production line for a cabinet company. AR 273, 323.2 He stopped working on December 14, 2017, after suffering a stroke. Doc. 13. His stroke manifested as left-sided paralysis and weakness and resulted in his hospitalization for four days. Id.

1 For a more thorough overview of the treatment records, see the Joint Statement of Facts (Doc. 13). 2 “AR” refers to the administrative record filed before, available at Docs. 10-2 to 10-14. A February 2018 treatment record from Alicaic’s primary care provider, Vinko Bogdanic, MD, noted that despite improvement, Alicaic still suffered “slight walking difficulties.” AR 739. He directed Alicaic to continue with home exercises and massage until his follow-up appointment with the hospital’s stroke department, which was scheduled for the end of March. Id. At that appointment at the stroke clinic, Alicaic complained of ongoing, daily left-sided pain in his arms and legs. AR 495, 498. At its worst, he reported losing control of his arms and legs and suffering increased weakness. Id. The neurologist prescribed gabapentin. AR 495. On objective examination, the neurologist observed normal sensation and tone but 4/5 strength in Alicaic’s left arm with notable breakaway weakness. AR 499. Based on his examination and “minor deficits,” the neurologist noted it seemed reasonable for Alicaic to return to work, and she suggested Alicaic check with his employer about lighter duties. AR 500. A few days later, however, Dr. Bogdanic extended Alicaic’s work excuse given his “ongoing issues” (including instances of confusion reported by Alicaic’s wife and father) and “slow recovery from his stroke.” AR 732, 734. Despite the use of gabapentin, Alicaic continued to visit Dr. Bogdanic every few weeks complaining of pain and weakness in his left arm and leg. In late April 2018, Dr. Bogdanic observed “visible left leg clumsiness” and noted Alicaic reported intense tingling in his left arm. AR 729. Dr. Bogdanic also noted Alicaic reported walking for an hour and a half every day, but that with this prolonged use, his leg became tired, making balance difficult. AR 731. In mid-June 2018, Dr. Bogdanic noted continued left-sided weakness and clumsiness. AR 724, 726. In early July 2018, Alicaic attempted to return to work, but he “was released back to physicians” after four hours due to trouble walking. AR 721. Dr. Bogdanic noted Alicaic’s stroke symptoms were “almost completely” resolved, but Alicaic continued to suffer “residual clumsiness on the left side,” mostly in his leg and arm, “with occasional pain.” Id. Dr. Bogdanic referred Alicaic to a neurologist. AR 723. Shortly thereafter, in July 2018, Alicaic met with neurologist Ivo Bekavac, MD, PhD. AR 481-82, 489. Alicaic reported that after his stroke, he continued to suffer intermittent weakness and numbness in his left arm and leg. AR 487, 489. On objective examination, Dr. Bekavac noted “no sign of weakness,” including 5/5 strength in all extremities, but did observe diminished sensation in his left arm and leg. Id. After ordering a brain MRI, which was normal, Dr. Bekavac diagnosed Alicaic with Derjerine- Roussy syndrome. AR 483, 487, 489. Derjerine-Roussy syndrome, also called central post-stroke pain or thalamic pain syndrome, is a rare post-stroke neuropathic pain syndrome that can onset days, months, or even years after a person suffers from a stroke, with symptoms usually beginning within the first six months.3 Symptoms include unexplained pain, tingling, or weakness on one side of the body that can be constant or intermittent.4 Derjerine-Roussy syndrome is poorly understood, which can make pain- management difficult.5 To begin, Dr. Bekavac discontinued gabapentin and prescribed oxcarbazepine. AR 487, 495, 1180, 1267. Oxcarbazepine helped. Alicaic reported in August 2018 (to both Drs. Bekavac and Bogdanic) “doing better,” with his arm “completely controlled” but “still struggling with the left leg weakness.” AR 486, 713. In September 2018, Dr. Bekavac noted Alicaic’s symptoms were stable with oxcarbazepine; the next week, Dr. Bogdanic noted the same, although Alicaic reported still experiencing some clumsiness and weakness. AR 485, 709-11. In early October 2018, Alicaic followed up with the stroke clinic,

Free access — add to your briefcase to read the full text and ask questions with AI

Alicaic v. Commissioner of Social Security, (N.D. Iowa 2022).

Alicaic v. Commissioner of Social Security (Alicaic v. Commissioner of Social Security) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bertha Eichelberger v. Jo Anne B. Barnhart
390 F.3d 584 (Eighth Circuit, 2004)
King v. Astrue
564 F.3d 978 (Eighth Circuit, 2009)
Kirby v. Astrue
500 F.3d 705 (Eighth Circuit, 2007)
Michele A. Herrmann v. Carolyn W. Colvin
772 F.3d 1110 (Seventh Circuit, 2014)
Tammy Sloan v. Andrew Saul
933 F.3d 946 (Eighth Circuit, 2019)